Temsirolimus/AZD 6244 for Treatment-naive With BRAF Mutant Unresectable Stage IV
Clinical trial NCT01166126 · TERMINATED
Trial details
- NCT number
- NCT01166126
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2012-06-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.